非経口栄養の世界市場：洞察、競合情勢、市場予測：2030年

世界の非経口栄養の市場規模は、2022年に60億8,435万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に6.04％のCAGRで拡大し、2030年には86億1,469万米ドルに達すると予測されています。非経口栄養市場は、主に小児における栄養不良の有病率の上昇により、大幅な市場成長を観察しています。さらに、栄養失調につながる未熟児出産の増加も、今後数年間の非経口栄養剤市場の推進に寄与するとみられています。さらに、政府のイニシアチブの高まりや非経口栄養のための新しいガイドラインの発行、がん、糖尿病、肥満などの様々な代謝および慢性疾患の有病率の上昇は、予測期間中に非経口栄養の需要の増加をサポートします。さらに、非経口栄養ソリューションや関連機器の承認や発売の急増に伴う研究開発活動の増加、市場における主要企業の存在なども、市場における非経口栄養の必要性を生み出します。

非経口栄養剤市場を牽引する重要な側面の1つは、世界中で栄養不良の有病率が上昇していることです。例えば、世界保健機関（WHO）の2022年の発表によると、2020年には世界で1億4,900万人の5歳未満児が発育不良（年齢に対して身長が低すぎる）、4,500万人が衰弱（身長に対して痩せすぎ）、3,890万人が過体重または肥満と推定されています。さらに、5歳未満の子どもの死亡の約45％は、栄養不良または栄養失調に関連しています。栄養不足は、子どもたちが一般的な感染症で死亡するリスクを高め、感染症の頻度と重症度を高め、回復を遅らせます。

さらに、ユニセフの2022年版報告書によると、2020年には世界で4,540万人の5歳未満児が栄養不良となり、うち1,360万人が重度の栄養不良でした。これは、それぞれ6.7％と2.0％の有病率に相当します。2020年には、消耗症に罹患している子どもの半数以上が南アジアに、4分の1近くがサハラ以南のアフリカに住んでおり、重度の消耗症に罹患している子どもについても同様の割合となっています。14.7％という南アジアの発育阻害有病率は、適切な治療プログラムによる介入を必要とする深刻な状況です。

このように、上記の情報源によると、栄養不良または栄養不良の有病率は世界のさまざまな地域で高く、非経口経路で栄養を供給することで治癒できるため、予測期間中に非経口栄養の需要が増加します。

当レポートでは、世界の非経口栄養市場について調査し、市場の概要とともに、栄養タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 非経口栄養市場レポートのイントロダクション

第2章 非経口栄養市場のエグゼクティブサマリー

第3章 規制分析

第4章 非経口栄養市場の主な要因分析

• 非経口栄養市場の促進要因
• 非経口栄養市場の抑制要因と課題
• 非経口栄養市場の機会

第5章 非経口栄養市場におけるポーターのファイブフォース分析

第6章 非経口栄養市場に対するCOVID-19の影響分析

第7章 非経口栄養市場の概要

• 栄養タイプ別
• エンドユーザー別
• 地域別

第8章 非経口栄養市場の企業と製品プロファイル

• B. Braun SE
• Fresenius Kabi India Pvt. Ltd.
• Baxter.
• Otsuka Pharmaceutical India Pvt. Ltd.
• Pfizer Inc.
• Grifols, S.A.
• JW Pharmaceutical
• Aculife Healthcare
• Kelun
• American Regent, Inc.
• EuroLife Healthcare Pvt. Ltd
• SGD Pharma
• icumedical
• Generic Specialties
• Vifor Pharma Management Ltd.
• Amanta Healthcare
• Anhui Medipharm Co, Ltd

第9章 KOL の見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis on Parenteral Nutrition Market
• Table 3: Parenteral Nutrition Market Analysis in Global (2021-2030)
• Table 4: Parenteral Nutrition Market Analysis in Global by Nutrient Type (2021-2030)
• Table 5: Parenteral Nutrition Market Analysis in Global by End-User (2021-2030)
• Table 6: Parenteral Nutrition Market Analysis in Global by Geography (2021-2030)
• Table 7: Parenteral Nutrition Market Analysis in North America (2021-2030)
• Table 8: Parenteral Nutrition Market Analysis in North America by Country (2021-2030)
• Table 9: Parenteral Nutrition Market Analysis in the US (2021-2030)
• Table 10: Parenteral Nutrition Market Analysis in Canada (2021-2030)
• Table 11: Parenteral Nutrition Market Analysis in Mexico (2021-2030)
• Table 12: Parenteral Nutrition Market Analysis in Europe (2021-2030)
• Table 13: Parenteral Nutrition Market Analysis in Europe by Country (2021-2030)
• Table 14: Parenteral Nutrition Market Analysis in France (2021-2030)
• Table 15: Parenteral Nutrition Market Analysis in Germany (2021-2030)
• Table 16: Parenteral Nutrition Market Analysis in the UK (2021-2030)
• Table 17: Parenteral Nutrition Market Analysis in Italy (2021-2030)
• Table 18: Parenteral Nutrition Market Analysis in Spain (2021-2030)
• Table 19: Parenteral Nutrition Market Analysis in the Rest of Europe (2021-2030)
• Table 20: Parenteral Nutrition Market Analysis in Asia-Pacific (2021-2030)
• Table 21: Parenteral Nutrition Market Analysis in Asia-Pacific by Country (2021-2030)
• Table 22: Parenteral Nutrition Market Analysis in China (2021-2030)
• Table 23: Parenteral Nutrition Market Analysis in Japan (2021-2030)
• Table 24: Parenteral Nutrition Market Analysis in India (2021-2030)
• Table 25: Parenteral Nutrition Market Analysis in Australia (2021-2030)
• Table 26: Parenteral Nutrition Market Analysis in South Korea (2021-2030)
• Table 27: Parenteral Nutrition Market Analysis in the Rest of Asia-Pacific (2021-2030)
• Table 28: Parenteral Nutrition Market Analysis in the Rest of the World (2021-2030)
• Table 29: Parenteral Nutrition Market Analysis in the Rest of the World by Region (2021-2030)
• Table 30: Parenteral Nutrition Market Analysis in the Middle East (2021-2030)
• Table 31: Parenteral Nutrition Market Analysis in Africa (2021-2030)
• Table 32: Parenteral Nutrition Market Analysis in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis on Parenteral Nutrition Market
• Figure 3: Parenteral Nutrition Market Analysis in Global (2021-2030)
• Figure 4: Parenteral Nutrition Market Analysis in Global by Nutrient Type (2021-2030)
• Figure 5: Parenteral Nutrition Market Analysis in Global by End-User(2021-2030)
• Figure 6: Parenteral Nutrition Market Analysis in Global by Geography (2021-2030)
• Figure 7: Parenteral Nutrition Market Analysis in North America (2021-2030)
• Figure 8: Parenteral Nutrition Market Analysis in North America by Country (2021-2030)
• Figure 9: Parenteral Nutrition Market Analysis in the US (2021-2030)
• Figure 10: Parenteral Nutrition Market Analysis in Canada (2021-2030)
• Figure 11: Parenteral Nutrition Market Analysis in Mexico (2021-2030)
• Figure 12: Parenteral Nutrition Market Analysis in Europe (2021-2030)
• Figure 13: Parenteral Nutrition Market Analysis in Europe by Country (2021-2030)
• Figure 14: Parenteral Nutrition Market Analysis in France (2021-2030)
• Figure 15: Parenteral Nutrition Market Analysis in Germany (2021-2030)
• Figure 16: Parenteral Nutrition Market Analysis in the UK (2021-2030)
• Figure 17: Parenteral Nutrition Market Analysis in Italy (2021-2030)
• Figure 18: Parenteral Nutrition Market Analysis in Spain (2021-2030)
• Figure 19: Parenteral Nutrition Market Analysis in the Rest of Europe (2021-2030)
• Figure 20: Parenteral Nutrition Market Analysis in Asia-Pacific (2021-2030)
• Figure 21: Parenteral Nutrition Market Analysis in Asia-Pacific by Country (2021-2030)
• Figure 22: Parenteral Nutrition Market Analysis in China (2021-2030)
• Figure 23: Parenteral Nutrition Market Analysis in Japan (2021-2030)
• Figure 24: Parenteral Nutrition Market Analysis in India (2021-2030)
• Figure 25: Parenteral Nutrition Market Analysis in Australia (2021-2030)
• Figure 26: Parenteral Nutrition Market Analysis in South Korea (2021-2030)
• Figure 27: Parenteral Nutrition Market Analysis in the Rest of Asia-Pacific (2021-2030)
• Figure 28: Parenteral Nutrition Market Analysis in the Rest of the World (2021-2030)
• Figure 29: Parenteral Nutrition Market Analysis in the Rest of the World by Region (2021-2030)
• Figure 30: Parenteral Nutrition Market Analysis in the Middle East (2021-2030)
• Figure 31: Parenteral Nutrition Market Analysis in Africa (2021-2030)
• Figure 32: Parenteral Nutrition Market Analysis in South America (2021-2030)
• Figure 33: Market Drivers
• Figure 34: Market Barriers
• Figure 35: Market Opportunities
• Figure 36: PORTER's Five Force Analysis

Parenteral Nutrition Market By Nutrient Type (Carbohydrates, Parenteral Lipid Emulsion, Single-Dose Amino Acid Solution, Trace Elements, And Vitamins & Minerals), By End-User (Children & Newborns, And Adults), and by geography is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing prevalence of malnutrition across the globe and the increasing initiatives by public and private companies to create awareness regarding the malnutrition and parenteral nutrition

The global parenteral nutrition market was valued at USD 6,084.35 million in 2022 and is likely to register a CAGR of 6.04% during the forecast period from 2024 to 2030 to reach USD 8,614.69 million by 2030. The parenteral nutrition market is observing substantial market growth primarily owing to the increasing prevalence of malnutrition among children. Moreover, the rising number of premature births ultimately leading to malnutrition will also aid in propelling the market of parenteral nutrition during the forthcoming years. Furthermore, the rising government initiatives and issuance of new guidelines for parenteral nutrition, increasing prevalence of various metabolic & chronic conditions such as cancers, diabetes, obesity, and others, will in turn support the increasing demand for parenteral nutrition during the forecast period. Additionally, the increasing research & developmental activities along with the surging approvals and launches of parenteral nutrition solutions and related devices, the presence of key players in the market, and other factors will create a requisite for parenteral nutrition in the market. Therefore, the market for parenteral nutrition is estimated to grow at a substantial CAGR during the forecast period from 2024 to 2030.

Parenteral Nutrition Market Dynamics:

One of the key aspects driving the parenteral nutrition market is the rising prevalence of malnutrition across the globe. For instance, as per the World Health Organization (WHO) 2022, in 2020, 149 million children under 5 were estimated to be stunted (too short for age), 45 million were estimated to be wasted (too thin for height), and 38.9 million were overweight or obese, globally. Moreover, around 45% of deaths among children under 5 years of age are linked to undernutrition or malnutrition. Undernutrition puts children at greater risk of dying from common infections, increases the frequency and severity of such infections, and delays recovery.

Further, the UNICEF 2022 report stated that in 2020 globally, 45.4 million children under five were wasted of which 13.6 million were severely wasted. This translates into a prevalence of 6.7 percent and 2.0 percent, respectively. In 2020, more than half of all children affected by wasting lived in South Asia and nearly one-quarter in sub-Saharan Africa, with similar proportions for children affected by severe wasting. At 14.7 percent, South Asia's wasting prevalence represents a situation requiring a serious need for intervention with appropriate treatment programs.

Thus, the above sources state that the prevalence of undernutrition or malnutrition is high across the different regions of the world, which can be cured by providing nutrition through parenteral routes, thereby leading to an increased demand for parenteral nutrition during the forecast period.

Moreover, as per the WHO 2022, an estimated 15 million babies are born prematurely every year which is more than 1 in 10 babies. Also, approximately 1 million children die each year due to complications of preterm birth. Parenteral nutrition must be initiated as soon as possible after delivery in very low birth weight (VLBW) preterm infants to prevent postnatal growth failure and improve neurodevelopmental outcomes. Thus, the increasing number of preterm delivery will ultimately increase the demand for parenteral nutrition, propelling market growth to unprecedented heights during the forecast period.

Additionally, the growing research and developmental activities, expanding product launches and approvals around the world, presence of a robust number of parenteral nutrition solutions in the pipeline, and strategic activities by the key players to increase the manufacturing and research of the parenteral nutrition will, in turn, bolster the market of parenteral nutrition. For instance, in February 2022, Fresenius Kabi, a global healthcare company, announced its plans to expand its Austrian facilities. The company will invest more than US$ 69.4 million through 2023 to expand capacity and upgrade infrastructure at its production plant in Graz and the packaging center nearby Werndorf, Europe.

Therefore, the factors stated above collectively will drive the overall parenteral nutrition market during the forecast period from 2024-2030.

However, lack of awareness regarding nutrition, stringent approval process, and others may prove to be challenging factors for parenteral nutrition market growth.

The parenteral nutrition market was moderately impacted during the period of COVID- 19 pandemic. During the initial stage of the pandemic, the sale of parenteral nutrition suffered a collapse owing to the imposition of strict lockdown rules, and disruption in manufacturing, and supply. Moreover, owing to the lockdown restrictions, halt in resources and supply chain, and the decreasing number of hospitalization visits for patients for the diagnosis & treatment of chronic diseases to curb the spread of infection, the demand for parenteral nutrition decreases. However, parenteral nutrition played an integral part in the treatment of severe or critical COVID-19 patients by providing all the necessary nutrition through parenteral routes. Additionally, owing to the imposition of the lockdown many low-economic groups suffered from starvation and undernutrition, ultimately increasing the demand for parenteral nutrition. Also, the regulatory authorities were continuously updating the guidelines for the mode of providing nutrition to COVID-19 patients. For instance, in March 2020, the Republic of Kenya Ministry of Health released some guidelines on nutrition management for COVID-19 for health workers in COVID-19 treatment and isolation centers. Henceforth, owing to the above factors the demand for parenteral nutrition increased during the pandemic and is anticipated to do the same during the forecast period (2022 - 2028).

Parenteral Nutrition Market Segment Analysis:

Parenteral Nutrition Market by Nutrient Type (Carbohydrates, Parenteral Lipid Emulsion, Single-Dose Amino Acid Solution, Trace Elements, and Vitamins & Minerals), End-user (Children & Newborns and Adults), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the nutrient type segment of the parenteral nutrition market, the single-dose amino acid solution is expected to have a significant revenue share in the year 2023. This was primarily owing to the rising demand and availability of single-dose amino acids in the market. Moreover, growing launches and strategic investments, and other activities relating to the segment single dose amino acids by key players in the market, and other factors will in turn be responsible for the surged demand for single-dose amino acids.

For instance, amino acids are highly used as a source of energy owing to their capability to treat mental fatigue, sprain, and muscle soreness among others. The single dose amino acids are used in the dietary management of inherited metabolic diseases providing specific amounts of amino acids that are unable to be achieved by dietary modification alone.

Moreover, single-dose amino acids are a range of pre-measured single-dose amino acids on a carbohydrate base, for use in the dietary management of inborn errors of protein metabolism. Also, they are specifically developed to offer a more accurate and reliable method of administration requiring quantities of individual amino acids.

Also, the pre-measured packets of single-dose amino acids solutions eliminate the need for weighing and provide on-the-go convenience, thereby acting as a factor responsible for the increased demand.

The newly available amino acid solutions possess fewer side effects, thereby enhancing patient benefits. For instance, Aminosyn, by Hospira, Inc., and Nirmin by Nirlife Pharma are a few of the single-dose amino acid solutions available in the market. The formulations of these mixed amino acids provide essential and nonessential amino acids; hence, the standard component acts as comprehensive parenteral nutrition for overall biological functioning.

Therefore, owing to the above-mentioned advantages, the demand for single-dose amino acids upsurges, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the global parenteral nutrition market during the forecast period.

North America is expected to dominate the overall Parenteral Nutrition Market:

Among all the regions, North America is expected to dominate global parenteral nutrition in the year 2023 and is expected to do the same during the forecast period from 2024-2030.

This can be ascribed to the increasing prevalence of malnutrition and chronic diseases. Further, the increasing geriatric population base prone to chronic diseases, rising product development activities, the growing initiatives for the awareness of malnutrition and its management, rising launches of parenteral nutrition solutions, presence of key market players in the region, and others are among the key factors that contribute to the growth of the parenteral nutrition market in North America.

For instance, according to the latest study done by the American Cancer Society, in 2022, there will be an estimated 1.9 million new cancer cases in the United States. The increasing incidence of cancers in the United States will increase the demand for parenteral nutrition as the persons undergoing treatment for cancer need parenteral nutrition to help meet their nutritional needs. A special mixture of glucose, protein, fat, vitamins, and minerals is given through an IV into the veins.

The latest data provided by the source Feeding America Organization stated that approximately 40 million Americans suffer from hunger in the US every year, which also includes more than 12 million children. These statistics are reflective of the impending diseases associated with malnourishment, which is one of the leading causative factors for the incrementing demand for parenteral nutrition in North America during the forecast period from 2022 - 2028.

Moreover, the surging launches of parenteral nutrition solutions, regulatory approvals, and other activities such as acquisitions, and agreements, in the region will lead to its increased demand in the market. For instance, in March 2022, Fresenius Kabi announced that the company has been granted an expanded indication for SMOFlipid® Lipid Injectable Emulsion (ILE) for pediatric patients in the United States, including term and preterm neonates, making it the first and only four-oil lipid emulsion for parenteral nutrition patients of every age. SMOFlipid can be used throughout the continuum of care, from the hospital to home care settings.

Additionally, the presence of advanced healthcare facilities and favorable reimbursement policies & regulations in the region has led to a high hospital admission rate, which supports the high product demand for parenteral nutrition in North America.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the parenteral nutrition market.

Parenteral Nutrition Market Key Players:

Some of the key market players operating in the parenteral nutrition market include B. Braun SE, Fresenius Kabi India Pvt. Ltd., Baxter., Otsuka Pharmaceutical India Pvt. Ltd., Pfizer Inc., Grifols, S.A., JW Pharmaceutical, Aculife Healthcare, Kelun, American Regent, Inc., EuroLife Healthcare Pvt. Ltd, SGD Pharma, icumedical, Generic Specialties, Vifor Pharma Management Ltd., Amanta Healthcare, Anhui Medipharm Co, Ltd., and others.

Recent Developmental Activities in the Parenteral Nutrition Market:

In July 2022, Micrel Medical, a manufacturer of medical devices with a focus on infusion therapy, and Baxter Healthcare (Baxter) inked a contract. Under this agreement, the businesses would market the infusion pump Micrel Mini Rythmic PN+ for parenteral nutrition (PN).

In September 2020, the U.S. Food and Drug Administration (FDA) gave its approval to Baxter International's new Clinimix Injections and Clinimix E Injection formulations. It is easier to reach patient protein targets with the new Clinimix formulations because they contain up to 80 g/L of amino acids, the highest amount of protein in any multi-chamber bag currently available in the United States also contain less fluid and dextrose than previous formulations.

Key Takeaways from the Parenteral Nutrition Market Report Study

• Market size analysis for current Parenteral Nutrition market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the parenteral nutrition market.
• Top key products/services/ developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global parenteral nutrition market.
• Various opportunities available for the other competitor in the parenteral nutrition market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current parenteral nutrition market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for parenteral nutrition market growth in the coming future?

Target Audience who can be benefited from this Parenteral Nutrition Market Report Study

• Parenteral nutrition products providers
• Research organizations and consulting companies
• Parenteral nutrition-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in parenteral nutrition
• Various end users who want to know more about the parenteral nutrition market and the latest developments in the parenteral nutrition market.

Frequently Asked Questions for the Parenteral Nutrition Market:

1. What is parenteral nutrition?

Parenteral nutrition (PN), or intravenous feeding, offers liquid nutrients like fats, proteins, vitamins, minerals, carbohydrates, and electrolytes. It is a part of specialized nutritional therapy that provides nutritional support to patients who are unable to utilize their gastrointestinal tract.

2. What is the global market for parenteral nutrition?

The global parenteral nutrition market was valued at USD 6,084.35 million in 2022 and is likely to register a CAGR of 6.04% during the forecast period from 2024 to 2030 to reach USD 8,614.69 million by 2030.

3. What are the drivers for the global parenteral nutrition market?

The parenteral nutrition market is witnessing positive market growth owing to the factors such as the increasing prevalence of malnutrition among children, rising government initiatives and issuance of new guidelines for parenteral nutrition, increasing prevalence of metabolic & chronic conditions, rising strategic steps by the key players for the development and manufacturing of parenteral nutrition, increasing new drug launches and approvals, presence of key players in the market, and others will create an exigency for the parenteral nutrition market.

4. Who are the key players operating in the global parenteral nutrition market?

Some of the key market players operating in the parenteral nutrition market include B. Braun SE, Fresenius Kabi India Pvt. Ltd., Baxter., Otsuka Pharmaceutical India Pvt. Ltd., Pfizer Inc., Grifols, S.A., JW Pharmaceutical, Aculife Healthcare, Kelun, American Regent, Inc., EuroLife Healthcare Pvt. Ltd, SGD Pharma, icumedical, Generic Specialties, Vifor Pharma Management Ltd., Amanta Healthcare, Anhui Medipharm Co, Ltd., and others.

5. Which region has the highest share of the parenteral nutrition market?

Among all the regions, North America is estimated to hold a significant revenue share in the global parenteral nutrition market. This can be ascribed to the increasing prevalence of malnutrition and chronic diseases. Further, the increasing geriatric population base prone to chronic diseases, rising product development activities, and the presence of key domicile players in the region are the reasons which act as a supportive factor for the North American parenteral nutrition market growth.

Table of Contents

1.Parenteral Nutrition Market Report Introduction

2. Parenteral Nutrition Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

4. Parenteral Nutrition Market Key Factors Analysis

• 4.1. Parenteral Nutrition Market Drivers
  • 4.1.1. The increasing prevalence of malnutrition among children
  • 4.1.2. Rising government initiatives and issuance of new guidelines for parenteral nutrition
  • 4.1.3. Increasing prevalence of metabolic & chronic conditions
• 4.2. Parenteral Nutrition Market Restraints and Challenges
  • 4.2.1. Lack of awareness regarding nutrition
  • 4.2.2. Stringent approval process
• 4.3. Parenteral Nutrition Market Opportunities
  • 4.3.1. Increasing approval of parenteral nutrition-related devices and drugs in emerging countries

5. Parenteral Nutrition Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Parenteral Nutrition Market

7. Parenteral Nutrition Market Layout

• 7.1. By Nutrient Type
  • 7.1.1. Carbohydrates
  • 7.1.2. Parenteral Lipid Emulsion
  • 7.1.3. Single-Dose Amino Acid Solution
  • 7.1.4. Trace Elements
  • 7.1.5. Vitamins & Minerals
• 7.2. By End-User
  • 7.2.1. Children & Newborns
  • 7.2.2. Adults
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. United States Parenteral Nutrition Market in USD million (2021-2030)
    • 7.3.1.2. Canada Parenteral Nutrition Market in USD million (2021-2030)
    • 7.3.1.3. Mexico Parenteral Nutrition Market in USD million (2021-2030)
  • 7.3.2. Europe
    • 7.3.2.1. France Parenteral Nutrition Market in USD million (2021-2030)
    • 7.3.2.2. Germany Parenteral Nutrition Market in USD million (2021-2030)
    • 7.3.2.3. United Kingdom Parenteral Nutrition Market in USD million (2021-2030)
    • 7.3.2.4. Italy Parenteral Nutrition Market in USD million (2021-2030)
    • 7.3.2.5. Spain Parenteral Nutrition Market in USD million (2021-2030)
    • 7.3.2.6. Rest of Europe Parenteral Nutrition Market in USD million (2021-2030)
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. China Parenteral Nutrition Market in USD million (2021-2030)
    • 7.3.3.2. Japan Parenteral Nutrition Market in USD million (2021-2030)
    • 7.3.3.3. India Parenteral Nutrition Market in USD million (2021-2030)
    • 7.3.3.4. Australia Parenteral Nutrition Market in USD million (2019-207)
    • 7.3.3.5. South Korea Parenteral Nutrition Market in USD million (2021-2030)
    • 7.3.3.6. Rest of Asia Pacific Parenteral Nutrition Market in USD million (2021-2030)
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. Middle East Parenteral Nutrition Market in USD million (2021-2030)
    • 7.3.4.2. Africa Parenteral Nutrition Market in USD million (2021-2030)
    • 7.3.4.3. South America Parenteral Nutrition Market in USD million (2021-2030)

8. Parenteral Nutrition Market Company and Product Profiles

• 8.1. B. Braun SE
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Fresenius Kabi India Pvt. Ltd.
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Baxter.
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Otsuka Pharmaceutical India Pvt. Ltd.
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Pfizer Inc.
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Grifols, S.A.
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. JW Pharmaceutical
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Aculife Healthcare
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Kelun
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. American Regent, Inc.
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. EuroLife Healthcare Pvt. Ltd
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. SGD Pharma
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. icumedical
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Generic Specialties
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Vifor Pharma Management Ltd.
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Amanta Healthcare
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. Anhui Medipharm Co, Ltd
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us